A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

Nature Genetics

Volumn 46, Issue 1, 2014, Pages 56-60

  Speedy, Helen E ^a   Di Bernardo, Maria Chiara ^a   Sava, Georgina P ^a   Dyer, Martin J S ^b   Holroyd, Amy ^a   Wang, Yufei ^a   Sunter, Nicola J ^c   Mansouri, Larry ^d   Juliusson, Gunnar ^e   Smedby, Karin E ^f   Roos, Göran ^g   Jayne, Sandrine ^b   Majid, Aneela ^b   Dearden, Claire ^a   Hall, Andrew G ^c   Mainou Fowler, Tryfonia ^h   Jackson, Graham H ⁱ   Summerfield, Geoffrey ^j   Harris, Robert J ^k   Pettitt, Andrew R ^k   Allsup, David J ^l   Bailey, James R ^m   Pratt, Guy ⁿ   Pepper, Chris ^o   Fegan, Chris ^p   Rosenquist, Richard ^d   Catovsky, Daniel ^a   Allan, James M ^c   Houlston, Richard S ^a   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UPPSALA UNIVERSITY   (Sweden)

^e LUND UNIVERSITY   (Sweden)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UMEÅ UNIVERSITY   (Sweden)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ ROYAL VICTORIA INFIRMARY   (United Kingdom)

^j QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^k UNIVERSITY OF LIVERPOOL   (United Kingdom)

^l HULL ROYAL INFIRMARY   (United Kingdom)

^m UNIVERSITY OF HULL   (United Kingdom)

ⁿ BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^o CARDIFF UNIVERSITY   (United Kingdom)

^p CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLPTM1L PROTEIN; IPCEF1 PROTEIN; POT1 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); MIDDLE AGED; MULTICENTER STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84891371778     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2843     Document Type: Article

References (45)

1. Stevenson, F.K. & Caligaris-Cappio, F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103, 4389-4395 (2004).
2. Goldin, L.R., Bjorkholm, M., Kristinsson, S.Y., Turesson, I. & Landgren, O. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica 94, 647-653 (2009).
3. Di Bernardo, M.C. et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40, 1204-1210 (2008).
4. Crowther-Swanepoel, D. et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat. Genet. 42, 132-136 (2010).
5. Slager, S.L. et al. Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood 120, 843-846 (2012).
6. Berndt, S.I. et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat. Genet. 45, 868-876 (2013).
7. Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817-825 (2010).
8. Houlston, R.S. et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet. 42, 973-977 (2010).
9. Chubb, D. et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat. Genet. 45, 1221-1225 (2013).
10. Jones, A.M. et al. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 61, 248-254 (2012).
11. Codd, V. et al. Identification of seven loci affecting mean telomere length and their association with disease. Nat. Genet. 45, 422-427 (2013).
12. Verma-Gaur, J., Hauser, J. & Grundstrom, T. Negative feedback regulation of antigen receptors through calmodulin inhibition of E2A. J. Immunol. 188, 6175-6183 (2012).
13. Ramsay, A.J. et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat. Genet. 45, 526-530 (2013).
14. Petersen, G.M. et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat. Genet. 42, 224-228 (2010).
15. Barrett, J.H. et al. Genome-wide association study identifies three new melanoma susceptibility loci. Nat. Genet. 43, 1108-1113 (2011).
16. Stacey, S.N. et al. New common variants affecting susceptibility to basal cell carcinoma. Nat. Genet. 41, 909-914 (2009).
17. Wang, Y. et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat. Genet. 40, 1407-1409 (2008).
18. Rothman, N. et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42, 978-984 (2010).
19. Bojesen, S.E. et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet. 45, 371-384 (2013).
20. Haiman, C.A. et al. A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat. Genet. 43, 1210-1214 (2011).
21. Karlsson, R. et al. Investigation of six testicular germ cell tumor susceptibility genes suggests a parent-of-origin effect in SPRY4. Hum. Mol. Genet. 22, 3373-3380 (2013).
22. Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848-1854 (1999).
23. Grundberg, E. et al. Mapping cis-and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 44, 1084-1089 (2012).
24. Di Bernardo, M.C., Broderick, P., Catovsky, D. & Houlston, R.S. Common genetic variation contributes significantly to the risk of developing chronic lymphocytic leukemia. Haematologica 98, e23-e24 (2013).
25. Swerdlow, S.H. et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon, France, 2008).
26. Catovsky, D. et al. Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Lancet 370, 230-239 (2007).
27. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006).
28. Penegar, S. et al. National study of colorectal cancer genetics. Br. J. Cancer 97, 1305-1309 (2007).
29. Eisen, T., Matakidou, A. & Houlston, R. Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer 8, 244 (2008).
30. Smedby, K.E. et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J. Natl. Cancer Inst. 97, 199-209 (2005).
31. van Dongen, J.J. et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17, 2257-2317 (2003).
32. van Krieken, J.H. et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21, 201-206 (2007).
33. Cawthon, R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 30, e47 (2002).
34. Nordfjäll, K., Osterman, P., Melander, O., Nilsson, P. & Roos, G. hTERT (-1327)T/C polymorphism is not associated with age-related telomere attrition in peripheral blood. Biochem. Biophys. Res. Commun. 358, 215-218 (2007).
35. Mansouri, L. et al. Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients. Am. J. Hematol. 88, 647-651 (2013).
36. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
37. Clayton, D.G. et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243-1246 (2005).
38. Petitti, D. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis (Oxford University Press, 1994).
39. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002).
40. Myers, S., Bottolo, L., Freeman, C., McVean, G. & Donnelly, P. A fine-scale map of recombination rates and hotspots across the human genome. Science 310, 321-324 (2005).
41. Gabriel, S.B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
42. Ward, L.D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
43. Boyle, A.P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797 (2012).
44. Cooper, G.M. et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 15, 901-913 (2005).
45. Yang, T.P. et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 26, 2474-2476 (2010).